• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Mass Device Q&A: Dave Kroll

Mass Device Q&A: Dave Kroll

October 5, 2009 By Jim Montalto

Dave Kroll, the founder and principal of Kroll Associates, works out of his office in western Massachusetts, which, according to him, proves there is life in design and product development beyond Worcester and the Greater Boston area.

In fact, Kroll sees his distance from Boston as an advantage, since he can also tap New York, Vermont, Connecticut, New Hampshire and beyond for new work.

He has clients in and around Boston, sure — one of his biggest is in Waltham — but his ties to New England universities, contractors and manufacturers, and his persistence in maintaining a presence with clients, either virtually or through office visits, keeps him on top of the industry.

MassDevice spoke with Kroll about his entry into the field and how his arsenal of resources and innovative style keeps him afloat in the sometimes turbulent medical devices market.

MassDevice: How did you get your start in the medical devices sphere?

David Kroll: My experience with medical device design began in the mid-’80s, working as an intern/entry-level industrial designer at Instrumentation Laboratory in Lexington, Mass. I was fortunate to work with a talented team headed by Steve Guerrera.

We worked on many blood chemistry systems that, back then, were among the latest advancements in automated handling and blood testing. Our focus was to integrate comprehensive industrial design with the systems, including ergonomics, user interface and marketable enclosure assemblies for a highly competitive industry.

Over the ’90s I developed a small industrial design consulting group that included clients in the medical, telecom, and consumer product industries. I also sub-contracted for larger design firms engaged in medical device development and continued that on occasion, until a few years back. I continue today with a mix of clients that include medical device manufacturers.

MassDevice: How do you set yourself apart from other design shops?

DK: Kroll Associates is primarily an industrial design firm that offers a full range of innovation and product development services, from early concepts through final manufacturing. We can engage in a product development program in most areas, including human factors research, fluidics, mechanical/electrical engineering, software and regulatory guidance.

We maintain ties with compliant contract manufacturers and specialized consultants in the field.

Projects have included digital fluoroscopes, 3D diagnostic imaging devices, augmentative communication devices and dental laboratory equipment. Some projects included focused brainstorm sessions to conceptualize new devices, material applications and novel approaches for device design.

I’m sure Kroll Associates has its own style of innovation and we may not be that different from the many competent, creative design firms in the industry. Having many medical device resources that include seasoned consultants and a scalable staff with passion for each project could be perceived as a high-value resource in the industry.

MassDevice: What’s on the horizon for Kroll?

DK: We are always targeting continued business in the industry,
potentially in 3D CT scan imaging, veterinary fluoroscopy and laboratory diagnostic equipment.

MassDevice:What’s the biggest lesson you’ve learned in leading a company?

DK: Have a clearly defined set of project specifications and a scope of work that itemizes all tasks needed to complete the project. This allows a proper team to be assembled and responsibilities to be tracked. I learned this from various mentors and professionals I have collaborated with over the years.

MassDevice:What strategies and tactics have you adopted to deal with the economic downturn, and what’s your forecast for short- and long-term prospects?

DK: Kroll Associates has stepped up its marketing efforts, networking and overhead savings plans to operate as cost-effectively as possible. Our prospects are supplemented by in-house product designs on spec and we are hoping to leverage our long-term relationships with vendors, associate consultants and marketing folks in the field.

MassDevice: What long-term effects will the recession have on your business?

DK: Some of our past clients are no longer in business, others are reducing R&D spending for the present. Long-term planning will be to keep operating costs under control and diversify our client base — that may include targeting projects in emerging industries such as green products, specialty catalog, consumer products and proprietary designs and IP.

MassDevice: We’re in a period of great flux in the medical industry. What do you think the medical device business will look like in 20 years?

DK: Obviously the advancements in this field will be amazing. If the economy stabilizes and capital flows properly to R&D and entities involved in it, I envision a slew of breakthrough devices that utilize the advances taking shape today, such as stem cell therapies, ultra-high-resolution imaging and non-invasive therapy, automated/robotic surgical assistance, bio-engineering, reconstructive equipment and novel drug delivery systems.

The business hopefully will focus on improved, user-centric devices for both patient and doctor and secure personal medical profiles that can be utilized in device applications.

MassDevice: What changes have you seen in the industry over the years?

DK: Information exchange, software and user interface improvements and many of the obvious electro-mechanical and embedded systems utilizing a wide range of capabilities. Also the industrial design of many of the devices is approaching the best man-machine interface yet.

MassDevice: What’s the biggest challenge confronting the devices industry, and how should it respond?

DK: Safety and finding cost-effective development programs. The industry needs more cross-pollination of experts and best integrity development programs too. Enterprise zoning for device manufacturing in Mass. should continue, develop and be incentivized.

MassDevice: Where do you see the next innovation coming from in this industry?

DK: It could come from smaller, focused design groups like Kroll Associates or from medical technicians who work with the devices on a
daily basis, those thinking of the next evolution, or easier-to-use, more
resolute versions of the product. Also, the practice of “biomimicry”
[observing designs of nature] will yield startling innovation.

MassDevice: When you’re building a team today, what areas do you put the most energy into, R&D, regulatory, sales and marketing, operations?

DK: Properly delivering the R&D efforts and striving to deliver above and beyond the expectations of the client. Becoming a true team player in the process and establishing a long-term relationship are also important. We should focus on keeping current with developments in the field and maintaining a strong professional network, too.

Filed Under: Business/Financial News, Research & Development Tagged With: MassDevice Q&A

In case you missed it

  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
  • FDA authorizes Labcorp’s non-prescription COVID-19 test that also detects flu, RSV
  • Massachusetts is competing for ARPA-H biomedical research center
  • Vivasure raises $23M initial Series D tranche; could reach up to $54M
  • Exactech announces breakthrough nod for JointMedica’s hip resurfacing system
  • Accuray names Sandeep Chalke as chief commercial officer
  • Labcorp launches at-home collection device for diabetes risk testing
  • Medtronic’s renal denervation system demonstrates better blood pressure control, time in range
  • iRhythm stays silent on federal grand jury subpoenas
  • Texas power grid struggles a year after cold stopped semiconductor plants
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
  • How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
  • Zimmer Biomet appoints new chief accounting officer
  • Cook Medical makes next-gen in vitro fertilization incubator available in U.S., Canada
  • Boston Scientific co-founder Peter Nicholas is dead at 80
  • How Boston Scientific uses clinical feedback to advance innovation
  • How Stryker includes users for product design in the digital age

RSS From Medical Design & Outsourcing

  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]
  • iRhythm stays silent on federal grand jury subpoenas
    More than one year after receiving the first of two federal grand jury subpoenas seeking information about its products and communications with the FDA, iRhythm Technologies has said little publicly about the matter. It would have been easy to miss the San Francisco-based cardiac monitor maker’s initial disclosure last summer. iRhythm (Nasdaq:IRTC) was without a… […]
  • How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
    A lot of talk around Dexcom (Nasdaq:DXCM) in the last couple of years has centered around its next-generation G7 continuous glucose monitor. The latest iteration of the company’s CGM platform has already garnered CE mark this year and awaits FDA approval, with some expectations for that to come after the American Diabetes Association’s Scientific Sessions next month. The company also presented… […]
  • Texas power grid struggles in heat one year after record cold stopped semiconductor plants
    A heatwave in Texas took at least six power plants offline Friday, with high temperatures forecasted to blaze throughout this week. A record cold snap in February 2021 took NXP Semiconductors and Samsung chip fabrication facilities offline for weeks, contributing to a global semicondcutor shortage that is still throttling medical device production. There’s no indication… […]
  • How Stryker includes users for product design in the digital age
    Medical device developers and manufacturers like Stryker (NYSE:SYK) are changing how they approach design as digital technology becomes more crucial. Four Stryker executives shared how the Kalamazoo, Michigan–based orthopedic device giant is thinking differently about medical product development and how health care providers and patients will ultimately use them. The DeviceTalks Boston panel of Stryker… […]
  • DermaSensor wins MedTech Innovator Mid-Stage Companies Pitch Event
    DermaSensor Inc. — the creator of a handheld, point-and-click device to quickly assess skin lesions for cancer risk — is the winner of the MedTech Innovator Mid-Stage Companies Pitch Event.  The Miami-based mid-stage company beat out 1,000 applicants, more than 20 of which competed on-site May 10–11, 2022 at DeviceTalks Boston. DermaSensor walked away with… […]
  • Steris rises on Street-beating Q4, sets fiscal 2023 guidance
    Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast. The infection prevention technology company — headquartered in Dublin, Ireland, and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months… […]
  • Lucira Health asks FDA for EUA on molecular at-home COVID/flu test
    Lucira Health (Nasdaq: LHDX) today said it has asked the FDA for an emergency use authorization (EUA) for its combination COVID-19 and flu test. Emeryville, California–based Lucira said the at-home test would be available with a prescription to test for SARS-CoV-2, Influenza A and Influenza B. The Nucleic Acid Amplification Test (NAAT) platform has a… […]
  • Device commercialization platform AcuityMD raises $31M Series A to fund R&D engineer hiring
    AcuityMD said today it has raised $31 million in Series A funding for its medical device commercialization platform. “With our new funding, we plan to double down on R&D by growing our engineering team from 15 to over 40 over the next year,” AcuityMD co-founder and CEO Michael Monovoukas said in a blog post. “We’ll… […]
  • Rockley Photonics announces $81.5M private placement
    Rockley Photonics (NYSE:RKLY) announced today that it entered into agreements for an $81.5 million private placement. Participating investors agreed to purchase $81.5 million in convertible senior secured notes (due 2026) and warrants to purchase 26.5 million Rockley ordinary shares at an exercise price of $5 per share, subject to certain anti-dilution adjustments. Warrants purchased in… […]
  • Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
    The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo,… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS